Ryo Obata
19PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (19)
Sort by Publication Date:
|Oct 28, 2025
Short-term changes in retinal pigment epithelium after anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration evaluated by polarization-sensitive optical coherence tomography.Ryo Terao, Kohdai Kitamoto, Shuichiro Aoki
|Aug 09, 2025
Aqueous humor cytokine profile in insufficient responder to aflibercept for neovascular age-related macular degeneration.Ryo Terao, Ryo Obata, Atsushi Okubo
|May 09, 2024
Three-year outcome of photodynamic therapy combined with VEGF inhibitor for pachychoroid neovasculopathy.Yoko Nomura, Shuichiro Aoki, Kohdai Kitamoto
|Jan 31, 2024
Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes.Nobuya Tanaka, Keiko Azuma, Shuichiro Aoki
|Mar 31, 2023
Cytokine profiles in the aqueous humor following brolucizumab administration for exudative age-related macular degeneration.Ryo Terao, Ryo Obata, Atsushi Okubo
|Sep 26, 2022
Intravenous lipo-prostaglandin E1 administration for patients with acute central retinal artery occlusion.Takafumi Suzuki, Ryo Obata, Tatsuya Inoue
Pageof 4
Frequent Collaborators
3 joint publications
Ryo Asaoka
2 joint publications
Hidenori Takahashi
2 joint publications
Makoto Aihara
2 joint publications
Yuri Fujino
2 joint publications
Satoru Inoda
2 joint publications
Takafumi Suzuki
2 joint publications
Manabu Miyata
2 joint publications
Ryo Terao
1 joint publications
Masahiro Yamanari
1 joint publications
Tatsuya Inoue
